SLC29A1 and gonorrhea: In our efforts to guide treatment decision for patients with PAC, we might better define gemcitabine sensitivity and resistance by an integrated analysis of the expression of dCK, hENT1 and hCNT3 in larger cohorts of patients, ideally within the context of a randomized controlled trial.